Zymeworks (ZYME) Tops Q4 EPS by 22c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. BIIB
7. CMG
8. TENB
9. KLAC
10. ETSY

Go back to Zymeworks (ZYME) Tops Q4 EPS by 22c

Zymeworks Provides Corporate Update and Reports Year-End 2021 Financial Results

February 24, 2022 4:15 PM EST

Enrollment on track for both pivotal trials of zanidatamab in 1L gastroesophageal adenocarcinoma (GEA) and 2L biliary tract cancer (BTC). Announced submission of abstracts for upcoming clinical data for the 2022 American Society for Clinical Oncology (ASCO) Annual Meeting. Financial position strengthened and cash runway extended following successful completion of equity offering in January. Announced Chris Astle, PhD as new Chief Financial Officer, with Neil Klompas continuing as Chief Operating Officer. Expected to exceed the previously announced workforce reduction of at least 25% by March 1, 2022, ahead of... More